Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis.
Journal: Clinical and translational science
Published: August 14, 2023
First-in-human study demonstrating the safety and clinical efficacy of novel anti-IL-17A monoclonal antibody CJM112 in moderate to severe plaque psoriasis.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: August 28, 2020
Showing 1-2 of 2
Last Updated: 09/26/2026